July 11, 2026 a 01:00 pm
CME: Analysts Ratings - CME Group Inc.
The recent analyst ratings for CME Group Inc. reflect a range of opinions from financial experts. With a mix of 'Strong Buy' and 'Hold' recommendations, the sentiment toward CME is cautiously optimistic. Analysts appear to appreciate the stability and diversified offerings of CME in the derivatives market, although there are some concerns about market volatility impacting future growth.
Historical Stock Grades
The ratings for CME as of July 2026 indicate a relatively balanced perspective with a notable amount of 'Strong Buy' and 'Buy' recommendations, as well as a significant presence of 'Hold' opinions. This suggests an overall stable but cautious view of the company's market potential.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 5 | |
| Buy | 5 | |
| Hold | 4 | |
| Sell | 1 | |
| Strong Sell | 2 |
Sentiment Development
Over the past months, CME has seen a stable number of 'Strong Buy' recommendations, while 'Hold' ratings have fluctuated slightly. The company has maintained a consistent presence in the 'Buy' category. However, the slight increase in 'Strong Sell' ratings indicates a need for vigilance in market activity.
- Stability in 'Strong Buy' recommendations.
- Fluctuations in 'Hold' ratings, indicating changing market circumstances.
- Slight increase in 'Strong Sell' ratings suggests caution.
Percentage Trends
The distribution of analyst ratings for CME has remained relatively consistent, with a balanced outlook. Since early 2025, there's been a gradual shift towards more neutral and cautionary sentiments, as seen in the slight increase in 'Hold' and 'Sell' ratings.
- Increase in 'Hold' ratings over time, indicating more caution.
- A slight downward trend in 'Strong Buy' and 'Buy' ratings reflects market uncertainties.
- Relative stability in 'Sell' and 'Strong Sell' categories.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-07-09 | Equal Weight | Equal Weight | Barclays |
| 2026-07-06 | Neutral | Neutral | UBS |
| 2026-07-02 | Outperform | Outperform | Raymond James |
| 2026-06-18 | Outperform | Market Perform | Keefe, Bruyette & Woods |
| 2026-06-11 | Buy | Neutral | Rothschild & Co |
Analyst Recommendations with Change of Opinion
The recent changes in analyst opinions for CME highlight a more positive outlook with a few upgrades being observed. This could signal growing confidence in the company's future performance despite lingering market uncertainties.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-18 | Outperform | Market Perform | Keefe, Bruyette & Woods |
| 2026-06-11 | Buy | Neutral | Rothschild & Co |
| 2026-03-04 | Hold | Buy | Argus Research |
| 2026-01-14 | Buy | Hold | TD Cowen |
| 2025-10-23 | Buy | Hold | Deutsche Bank |
Interpretation
The market's sentiment toward CME suggests a stable outlook with cautious optimism. Several upgrades indicate a potential increase in confidence among analysts, albeit tempered by lingering market uncertainties. The balance of ratings across categories suggests that while some perceive potential for growth and performance, others remain wary of the volatile market conditions. The stability in the recommendations showcases a consistent outlook from analysts.
Conclusion
Overall, CME Group Inc. appears to present opportunities for growth, as indicated by the analyst upgrades. However, the increase in 'Hold' and 'Strong Sell' recommendations highlights potential risks associated with market volatility. Analysts remain cautiously optimistic, exhibiting both confidence in the company's abilities and prudence given current economic conditions. This blend of ratings reflects a nuanced understanding of the current market environment, suggesting caution but also potential for future gains.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years